News coverage about United-Guardian (NASDAQ:UG) has trended somewhat positive on Tuesday, Accern Sentiment Analysis reports. The research group scores the sentiment of press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. United-Guardian earned a news impact score of 0.13 on Accern’s scale. Accern also gave headlines about the company an impact score of 45.8492666221388 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
Separately, ValuEngine upgraded United-Guardian from a “sell” rating to a “hold” rating in a research note on Thursday, July 27th.
United-Guardian (UG) traded up 1.91% during trading on Tuesday, hitting $16.00. The stock had a trading volume of 18,394 shares. United-Guardian has a 52-week low of $13.75 and a 52-week high of $18.05. The company’s 50 day moving average is $15.41 and its 200 day moving average is $15.05. The firm has a market cap of $73.50 million, a PE ratio of 27.30 and a beta of 0.23.
United-Guardian (NASDAQ:UG) last announced its quarterly earnings data on Wednesday, May 10th. The company reported $0.14 earnings per share for the quarter. The firm had revenue of $2.79 million for the quarter. United-Guardian had a net margin of 23.80% and a return on equity of 18.72%.
COPYRIGHT VIOLATION WARNING: “United-Guardian (UG) Receiving Somewhat Favorable News Coverage, Study Finds” was reported by BBNS and is the sole property of of BBNS. If you are viewing this story on another site, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this story can be read at https://baseballnewssource.com/markets/united-guardian-ug-receiving-somewhat-favorable-news-coverage-study-finds/1409182.html.
United-Guardian, Inc manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, healthcare products and specialty industrial products. The Company also conducts research and product development, primarily related to the development of cosmetic and personal care products.
Receive News & Ratings for United-Guardian Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United-Guardian Inc. and related companies with our FREE daily email newsletter.